| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5061704 | Economics Letters | 2008 | 4 Pages |
Abstract
We use a duration model to find evidence that drug exit is exacerbated by generic competition. However, the impact on drug exit of competition with other branded drugs within a drug's therapeutic class is not statistically significant.
Related Topics
Social Sciences and Humanities
Economics, Econometrics and Finance
Economics and Econometrics
Authors
Suchin Virabhak, Wook Sohn,